3-fluoro-4-[4-[2-(3,5 dimethylphenyl)pyrrolidin-1-yl methyl]phenoxy]benzamide compound

Abstract

A selective kappa opioid receptor antagonist useful for treating ethanol use disorder withdrawal and anxiety, and / or depression, or schizophrenia as independent comorbid conditions. In particular, disclosed is a compound 3 Fluoro-4-[4-[2-(3, 5dimethylphenyl)pyrrolidin-l-yl methyl]phenoxylbenzamide and a pharmaceutical composition comprising thereof for use in therapy.